NIH-funded research NIH-funded research

Quit-smoking support for adults with HIV or TB in South Africa

Official title: Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa

Funded at Massachusetts General Hospital · NIH-11379030 · Data updated 2026-11-12

This project will create and try smoking-cessation support for adults with HIV or TB in South Africa to help them quit and stay on treatment.

More Smoking research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2023
Project endMay 31, 2026
Funding year2025
Award (this year)$81,305
NIH project number3R34DA057169-03S1
Project IDNIH-11379030 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older in South Africa who are living with HIV and/or recently diagnosed with TB and who currently smoke would be the ideal participants.

Less likely to help

People who do not smoke, are under the study age cutoff, live outside South Africa, or are unwilling to attend clinic visits and counseling are unlikely to benefit from joining.

What this research studies

If you join, you would be offered counseling based on cognitive behavioral therapy that is adapted for people living with HIV and those being treated for TB in South Africa. The team will tailor the program to local clinics and ways of delivering care, then try it out with people who smoke to see if it is acceptable and practical. They will include measures to support taking HIV and TB medicines and will check smoking status with biological tests. Study staff will also track treatment adherence and health indicators like viral load and TB treatment outcomes to see if quitting helps overall care.

Why it matters

Potential benefit: If successful, this could help people with HIV or TB stop smoking and improve adherence to HIV and TB treatments, potentially reducing illness and death.

How similar studies have gone: Earlier trials by the team showed higher biologically-verified quit rates among people with HIV in the US and improved ART adherence in Cape Town, supporting this approach though combining smoking cessation with HIV/TB care in South Africa is a new application.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: O'cleirigh, Conall Michael — Massachusetts General Hospital
  • Study coordinator: O'cleirigh, Conall Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.